Impact of methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism on the outcome of methotrexate treatment in a sample of Egyptian rheumatoid arthritis patientsFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 7 March 2018

References

• I.McInnesG.SchettThe pathogenesis of rheumatoid arthritisN Engl J Med365201122052219
   PubMed Web of Science ®Google Scholar
• D.AssayagJ.LeeT.KingJr.Rheumatoid arthritis associated interstitial lung disease: a reviewMedicina (Buenos Aires)742014158165
   PubMed Web of Science ®Google Scholar
• R.HoovestolT.MikulsEnvironmental exposures and rheumatoid arthritis riskCurr Rheumatol Rep132011431439
   PubMed Web of Science ®Google Scholar
• N.LiJ.C.WangT.H.LiangPathologic finding of increased expression of interleukin-17 in the synovial tissue of rheumatoid arthritis patientsInt J Clin Exp Pathol6201313751379
   PubMed Web of Science ®Google Scholar
• M.MelladoL.Martínez-MuñozG.CascioP.LucasJ.L.PablosJ.M.Rodríguez-FradeT cell migration in rheumatoid arthritisFront Immunol62015384
   PubMed Web of Science ®Google Scholar
• J.SmolenD.AletahaM.KoellerNew therapies for the treatment of rheumatoid arthritisLancet370200718611874
   PubMed Web of Science ®Google Scholar
• R.CálizJ.Del AmoA.BalsaThe C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis populationScand J Rheumatol4120121014
   PubMed Web of Science ®Google Scholar
• Y.GhodkeA.ChopraK.JoshiB.PatwardhanAre Thymidylate synthase and Methylenetetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?Clin Rheumatol272008787789
   PubMed Web of Science ®Google Scholar
• A.LimaJ.MonteiroM.BernardesPrediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphismsBiomed Res Int20142014https://doi.org/10.1155/2014/368681
   Web of Science ®Google Scholar
• F.MalikP.RanganathanMethotrexate pharmacogenetics in rheumatoid arthritis: a status reportPharmacogenomics142013305314
   PubMed Web of Science ®Google Scholar
• H.WangJ.WangL.ZhaoX.LiuW.MiMethylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studiesBMC Med Genet13201277
   PubMed Web of Science ®Google Scholar
• R.RozenGenetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR)ThrombHaemost781997523526
   Google Scholar
• D.VejnovicV.MilicT.DamnjanovicAnalysis of association between polymorphisms of MTHFR, MTHFD1 and RFC1 genes and efficacy and toxicity of methotrexate in rheumatoid arthritis patientsGenetika482016395408
   Google Scholar
• I.WeisbergP.TranB.ChristensenS.SibaniR.RozenA second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activityMol Genet Metab641998169172
   PubMed Web of Science ®Google Scholar
• S.A.OwenS.L.HiderP.MartinI.N.BruceA.BartonW.ThomsonGenetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.Pharmacogenomics J132012227234
   PubMed Web of Science ®Google Scholar
• Van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB, editors. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Seminars in arthritis and rheumatism. Elsevier; 1998.
   Google Scholar
• M.FenechThe role of folic acid and Vitamin B12 in genomic stability of human cellsMutation Res/Fundam Mol Mech Mutagenesis47520015767
   PubMed Web of Science ®Google Scholar
• T.KatoA.HamadaS.MoriH.SaitoGenetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritisDrug Metab Pharmacokinet272012192199
   PubMed Web of Science ®Google Scholar
• J.A.WesselsBouwstra.K.de VriesB.T.HeijmansEfficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with singlenucleotide polymorphisms in genes coding for folate pathway enzymesArthritis Rheum54200610871095
   PubMed Web of Science ®Google Scholar
• Y.Ghodke-PuranikA.S.PuranikP.ShintreFolate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritisPharmacogenomics16201520192034
   PubMed Web of Science ®Google Scholar
• M.KurzawskiA.PawlikK.SafranowM.HerczynskaM.Drozdzik677C> T and 1298A> C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritisPharmacogenomics8200715511559
   PubMed Web of Science ®Google Scholar
• W.UranoA.TaniguchiaH.YamanakaaPolymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the ef®cacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analysesPharmacogenetics122002183190
   PubMedGoogle Scholar
• M.TaraborelliL.AndreoliS.ArchettiM.FerrariR.CattaneoA.TincaniMethylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patientsClin Exp Rheumatol272008499502
   Web of Science ®Google Scholar
• K.KumagaiK.HiyamaT.OyamaH.MaedaN.KohnoPolymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritisInt J Mol Med112003593
   PubMed Web of Science ®Google Scholar
• P.B.GrabarD.LogarB.LestanV.DolzanGenetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolismEur J Clin Pharmacol64200810571068
   PubMed Web of Science ®Google Scholar
• Y.C.LeeJ.CuiK.H.CostenbaderN.A.ShadickM.E.WeinblattE.W.KarlsonInvestigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexateRheumatology (Oxford, England)482009613
   PubMed Web of Science ®Google Scholar
• M.P.IqbalA.A.AliN.MehboobaliK.IqbalLack of association between MTHFR gene polymorphisms and response to methotrexate treatment in Pakistani patients with rheumatoid arthritisPak J Pharm Sci28201517891792
   PubMed Web of Science ®Google Scholar
• J.ŚwierkotR.ŚlęzakP.KarpińskiAssociations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR, TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritisPol Arch Med Wewn1252015152161
   PubMed Web of Science ®Google Scholar
• J.-Y.ChoeH.LeeH.-Y.JungS.-H.ParkS.-C.BaeS.-K.KimMethylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritisRheumatol Int32201218371842
   PubMed Web of Science ®Google Scholar
• L.A.DavisB.PolkA.MannFolic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritisClin Exp Rheumatol322014324
   PubMed Web of Science ®Google Scholar
• T.DervieuxN.GreensteinJ.KremerPharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritisArthritis Rheum54200630953103
   PubMed Web of Science ®Google Scholar
• B.JenkoL.LusaM.TomsicS.PraprotnikV.DolzanClinical–pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritisPharmacogenomics J2016https://doi.org/10.1038/tpj
   PubMed Web of Science ®Google Scholar
• A.LimaM.BernardesH.SousaSLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patientsPharmacogenomics152014807820
   PubMed Web of Science ®Google Scholar